Defunct Company
Total Trials
11
As Lead Sponsor
As Collaborator
0
Total Enrollment
643
NCT02555410
Seizure Detection and Warning System in Epilepsy Patients
Phase: N/A
Role: Lead Sponsor
Start: Jan 31, 2013
Completion: Jul 7, 2017
NCT01874600
Seizure Detection and Warning System for Epilepsy Patients
Start: Jul 31, 2013
Completion: Dec 31, 2019
NCT02371200
Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients
Start: Apr 30, 2015
Completion: Feb 28, 2018
NCT02752373
A Health Economic Study Evaluating the Brain Sentinel® GTC Seizure Detection and Information Systems Impact on Epilepsy and Healthcare Utilization
Start: May 31, 2016
Completion: Feb 28, 2017
NCT03013348
Automated Identification of Psychogenic Nonepileptic Seizures
Start: Jan 31, 2017
Completion: Aug 31, 2020
NCT03169751
An Exploratory Trial Using sEMG to Differentiate PNES From Epileptic Seizures
Start: Sep 1, 2017
Completion: Feb 1, 2020
NCT03313362
Detecting PNES With Single-channel sEMG
Start: Nov 3, 2017
Completion: Feb 29, 2020
NCT03484598
Clinical Utility of the SPEAC® System: A Case Series
Start: Sep 1, 2018
Completion: Apr 30, 2020
NCT03742661
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a New Diagnosis
Start: Nov 2, 2018
Completion: Jan 31, 2026
NCT03741192
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patient's Refractory to AEDs
Start: Jan 31, 2020
NCT03741205
Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a Recent Non-diagnostic EMU Visit
Start: Jul 1, 2020